Advertisement

Journal of Molecular Neuroscience

, Volume 67, Issue 1, pp 133–141 | Cite as

Hydrogen Sulfide Protects Hippocampal Neurons Against Methamphetamine Neurotoxicity Via Inhibition of Apoptosis and Neuroinflammation

  • Fateme Ghanbari
  • Mehdi KhaksariEmail author
  • Golamhassan Vaezi
  • Vida Hojati
  • Abdolhossein Shiravi
Article
  • 91 Downloads

Abstract

Methamphetamine (METH) known as a highly neurotoxic compound associated with irreversible brain cell damage that results in neurological and psychiatric abnormalities. The mechanisms of METH intoxication mainly involve intraneuronal events including oxidative stress, excitotoxicity, and dopamine oxidation. Based on recent studies, H2S can protect neurons through anti-inflammatory, antioxidant, and antiapoptotic mechanisms. Therefore, we aimed to study the effects of protection of H2S against METH neurotoxicity. The 72 male Wistar rats were randomly allocated into six groups: control (n, 12), H2S (n, 12), METH (n, 12), METH + H2S 1 mg/kg (n, 12), METH + H2S 5 mg/kg (n, 12), and METH + H2S 10 mg/kg (n, 12) groups, (NaHS as a H2S donor; 1, 5, 10 mg/kg). METH neurotoxicity was induced by 40 mg/kg of METH in four intraperitoneal (IP) injections (e.g., 4 × 10 mg/kg q. 2 h, IP). NaHS was administered at 30 min, 24 h, and 48 h after the final injection of METH. Seven days after METH injection, the brains were removed for biochemical assessments, glial fibrillary acidic protein (GFAP), and caspase-3 immunohistochemistry staining. H2S treatment could significantly increase both superoxide dismutase and glutathione (P < 0.01), and a reduction was observed in malondialdehyde (P < 0.05) and TNF-α (P < 0.01) versus the METH group. Moreover, H2S could significantly decrease caspase-3 and GFAP-positive cells in the CA1 region of the hippocampus (P < 0.01) compared to the METH group. According to the findings, H2S makes significant neuroprotective impacts on METH neurotoxicity due to its antioxidant and anti-inflammatory activities.

Keywords

Hydrogen sulfide Methamphetamine neurotoxicity Apoptosis Neuroinflammation Antioxidant activity 

Notes

Acknowledgements

The authors are very thankful to Pirasteh Norozi, Mahnaz Mesripour Alavije, and Mohammad Taghi Rahimi for their kind and helpful collaborations.

Compliance with Ethical Standards

Ethical Approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. Abe K, Kimura H (1996) The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16:1066–1071CrossRefGoogle Scholar
  2. Aboutaleb N, Shamsaei N, Khaksari M, Erfani S, Rajabi H, Nikbakht F (2015) Pre-ischemic exercise reduces apoptosis in hippocampal CA3 cells after cerebral ischemia by modulation of the Bax/Bcl-2 proteins ratio and prevention of caspase-3 activation. J Physiol Sci 65:435–443CrossRefGoogle Scholar
  3. Aboutaleb N, Shamsaei N, Rajabi H, Khaksari M, Erfani S, Nikbakht F, Motamedi P, Shahbazi A (2016) Protection of hippocampal CA1 neurons against ischemia/reperfusion injury by exercise preconditioning via modulation of Bax/Bcl-2 ratio and prevention of caspase-3 activation. Basic and clinical neuroscience 7:21PubMedPubMedCentralGoogle Scholar
  4. Alshehri FS, Althobaiti YS, Sari Y (2017) Effects of administered ethanol and methamphetamine on glial glutamate transporters in rat striatum and hippocampus. J Mol Neurosci 61:343–350CrossRefGoogle Scholar
  5. Asanuma M, Tsuji T, Miyazaki I, Miyoshi K, Ogawa N (2003) Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug. Neurosci Lett 352:13–16CrossRefGoogle Scholar
  6. Berman SB, Zigmond MJ, Hastings TG (1996) Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J Neurochem 67:593–600CrossRefGoogle Scholar
  7. Bowyer JF, Clausing P, Gough B, Slikker W Jr, Holson RR (1995) Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen. Brain Res 699:62–70CrossRefGoogle Scholar
  8. Cadet JL, Jayanthi S, Deng X (2003) Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J 17:1775–1788CrossRefGoogle Scholar
  9. Cadet JL, Krasnova IN, Jayanthi S, Lyles J (2007) Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox Res 11:183–202CrossRefGoogle Scholar
  10. Casamenti F, Prosperi C, Scali C, Giovannelli L, Colivicchi M, Faussone-Pellegrini M, Pepeu G (1999) Interleukin-1β activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer’s disease. Neuroscience 91:831–842CrossRefGoogle Scholar
  11. Chen W-L, Niu Y-Y, Jiang W-Z, Tang H-L, Zhang C, Xia Q-M, Tang X-Q (2015) Neuroprotective effects of hydrogen sulfide and the underlying signaling pathways. Rev Neurosci 26:129–142CrossRefGoogle Scholar
  12. Cubells JF, Rayport S, Rajendran G, Sulzer D (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 14:2260–2271CrossRefGoogle Scholar
  13. Davidson C, Gow AJ, Lee TH, Ellinwood EH (2001) Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Rev 36:1–22CrossRefGoogle Scholar
  14. Erfani S, Aboutaleb N, Oryan S, Shamsaei N, Khaksari M, Kalalian-Moghaddam H, Nikbakht F (2015a) Visfatin inhibits apoptosis and necrosis of hippocampus CA3 cells following transient global ischemia/reperfusion in rats. Int J Pept Res Ther 21:223–228CrossRefGoogle Scholar
  15. Erfani S, Khaksari M, Oryan S, Shamsaei N, Aboutaleb N, Nikbakht F (2015b) Nampt/PBEF/visfatin exerts neuroprotective effects against ischemia/reperfusion injury via modulation of Bax/Bcl-2 ratio and prevention of caspase-3 activation. J Mol Neurosci 56:237–243CrossRefGoogle Scholar
  16. Erfani S, Moghimi A, Aboutaleb N, Khaksari M (2018) Nesfatin-1 improve spatial memory impairment following transient global cerebral ischemia/reperfusion via inhibiting microglial and caspase-3 activation. J Mol Neurosci 65:377–384CrossRefGoogle Scholar
  17. Gelbard HA, Dzenko KA, Diloreto D, Del Cerro C, Del Cerro M, Epstein LG (1993) Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev Neurosci 15:417–422CrossRefGoogle Scholar
  18. Gheibi S, Aboutaleb N, Khaksari M, Kalalian-Moghaddam H, Vakili A, Asadi Y, Mehrjerdi FZ, Gheibi A (2014) Hydrogen sulfide protects the brain against ischemic reperfusion injury in a transient model of focal cerebral ischemia. J Mol Neurosci 54:264–270CrossRefGoogle Scholar
  19. Gonçalves J, Martins T, Ferreira R, Milhazes N, Borges F, Ribeiro CF, Malva JO, Macedo TR, Silva AP (2008) Methamphetamine-induced early increase of IL-6 and TNF-α mRNA expression in the mouse brain. Annals of the New York Academy of Sciences 1139:103–111CrossRefGoogle Scholar
  20. Gonçalves J, Baptista S, Martins T, Milhazes N, Borges F, Ribeiro CF, Malva JO, Silva AP (2010) Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur J Neurosci 31:315–326CrossRefGoogle Scholar
  21. Hers H (1963) α-Glucosidase deficiency in generalized glycogen-storage disease (Pompe’s disease). Biochem J 86:11–16CrossRefGoogle Scholar
  22. Hu LF, Wong PTH, Moore PK, & Bian JS (2007). Hydrogen sulfide attenuates lipopolysaccharideinduced inflammation by inhibition of p38 mitogen‐activated protein kinase in microglia. Journal of neurochemistry, 100(4):1121–1128Google Scholar
  23. Jayanthi S, Ladenheim B, Andrews A, Cadet J (1999) Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (ecstasy). Neuroscience 91:1379–1387CrossRefGoogle Scholar
  24. Kadiiska MB, Gladen B, Baird D, Graham L, Parker C, Ames B, Basu S, Fitzgerald G, Lawson J, Marnett L (2005) Biomarkers of oxidative stress study: III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med 38:711–718CrossRefGoogle Scholar
  25. Kato H, Araki T, Imai Y, Takahashi A, Itoyama Y (2003) Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(−)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson’s disease. J Neurol Sci 208:9–15CrossRefGoogle Scholar
  26. Kimura H (2012) Hydrogen sulfide: production, release, and functions. Nihon yakurigaku zasshi Folia pharmacologica Japonica 139:6–8CrossRefGoogle Scholar
  27. Lee YW, Son KW, Flora G, Hennig B, Nath A, Toborek M (2002) Methamphetamine activates DNA binding of specific redox-responsive transcription factors in mouse brain. J Neurosci Res 70:82–89CrossRefGoogle Scholar
  28. Li L, Mohamed MSB, Moore PK (2013) Multiple roles of H 2 S in inflammation: a new class of therapeutics? Hydrogen Sulfide and its Therapeutic Applications. Springer, Vienna, p 63–82Google Scholar
  29. Marshall JF, O’Dell SJ (2012) Methamphetamine influences on brain and behavior: unsafe at any speed? Trends Neurosci 35:536–545CrossRefGoogle Scholar
  30. Mehrjerdi FZ, Aboutaleb N, Pazoki-Toroudi H, Soleimani M, Ajami M, Khaksari M, Safari F, Habibey R (2015) The protective effect of remote renal preconditioning against hippocampal ischemia reperfusion injury: role of KATP channels. J Mol Neurosci 57:554–560CrossRefGoogle Scholar
  31. Michiels C, Raes M, Toussaint O, Remacle J (1994) Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med 17:235–248CrossRefGoogle Scholar
  32. Miljković D, Timotijević G, & Stojković MM. (2011). Astrocytes in the tempest of multiple sclerosis. FEBS letters, 585(23):3781–3788Google Scholar
  33. Morgan JE (2000) Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage. Eye 14:437–444CrossRefGoogle Scholar
  34. Northrup NA, Yamamoto BK (2011) Neuroimmune pharmacology from a neuroscience perspective. J NeuroImmune Pharmacol 6:10–19CrossRefGoogle Scholar
  35. O’Dell SJ, Weihmuller FB, Marshall JF (1991) Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res 564:256–260CrossRefGoogle Scholar
  36. Pereira FC, Lourenço E, Milhazes N, Morgadinho T, Ribeiro CF, Ali SF, Macedo TR (2006) Methamphetamine, morphine, and their combination. Annals of the New York Academy of Sciences 1074:160–173CrossRefGoogle Scholar
  37. Qin L, Liu Y, Cooper C, Liu B, Wilson B, & Hong JS (2002). Microglia enhance β‐amyloid peptideinduced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. Journal of neurochemistry, 83(4):973–983.Google Scholar
  38. Robbins DS, Shirazi Y, Drysdale B, Lieberman A, Shin H, Shin M (1987) Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 139:2593–2597PubMedGoogle Scholar
  39. Seiden LS, Sabol KE (1996) Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. NIDA Res Monogr 163:1276Google Scholar
  40. Stephans SE, Yamamoto BK (1994) Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 17:203–209CrossRefGoogle Scholar
  41. Szabó C (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6:917–935CrossRefGoogle Scholar
  42. Tang X-Q, Shen X-T, Huang Y-E, Ren Y-K, Chen R-Q, Hu B, He J-Q, Yin W-L, Xu J-H, Jiang Z-S (2010) Hydrogen sulfide antagonizes homocysteine-induced neurotoxicity in PC12 cells. Neurosci Res 68:241–249CrossRefGoogle Scholar
  43. Thomas DM, Walker PD, Benjamins JA, Geddes TJ, Kuhn DM (2004) Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther 311:1–7CrossRefGoogle Scholar
  44. Tomozawa Y, Yabuuchi K, Inoue T, Satoh M (1995) Participation of cAMP and cAMP-dependent protein kinase in β-adrenoceptor-mediated interleukin-1β mRNA induction in cultured microglia. Neurosci Res 22:399–409CrossRefGoogle Scholar
  45. Tyagi N, Moshal KS, Sen U, Vacek TP, Kumar M, Hughes WM Jr, Kundu S, Tyagi SC (2009) H2S protects against methionine–induced oxidative stress in brain endothelial cells. Antioxid Redox Signal 11:25–33CrossRefGoogle Scholar
  46. Westmoreland SV, Kolson D, Gonzalez-Scarano F (1996) Toxicity of TNFα and platelet activating factor for human NT2N neurons: a tissue culture model for human immunodeficiency virus dementia. J Neurovirol 2:118–126CrossRefGoogle Scholar
  47. Wrona MZ, Yang Z, Zhang F, Dryhurst G (1997) Potential new insights into the molecular mechanisms of methamphetamine-induced neurodegeneration. NIDA Res Monogr 173:146–174PubMedGoogle Scholar
  48. Xuan A, Long D, Li J, Ji W, Zhang M, Hong L, Liu J (2012) Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer’s disease. J Neuroinflammation 9:202CrossRefGoogle Scholar
  49. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S (2008) H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine γ-lyase. Science 322:587–590CrossRefGoogle Scholar
  50. Yu S, Zhu L, Shen Q, Bai X, Di X (2015) Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology. Behav Neurol 2015:1–11Google Scholar
  51. Zhang L-M, Jiang C-X, Liu D-W (2009) Hydrogen sulfide attenuates neuronal injury induced by vascular dementia via inhibiting apoptosis in rats. Neurochem Res 34:1984–1992CrossRefGoogle Scholar
  52. Zhao J, O’Connor T, Vassar R (2011) The contribution of activated astrocytes to Aβ production: implications for Alzheimer’s disease pathogenesis. J Neuroinflammation 8:150CrossRefGoogle Scholar
  53. Zou JY, Crews FT (2005) TNFα potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NFκB inhibition. Brain Res 1034:11–24CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Biology, Damghan BranchIslamic Azad UniversityDamghanIran
  2. 2.Addiction Research CenterShahroud University of Medical SciencesShahroudIran

Personalised recommendations